Bentham Science Logo

Clinical Cancer Drugs

Volume 6, 2 Issues, 2019
ISSN: 2212-6988 (Online)
ISSN: 2212-697X (Print)
This journal supports open access

Contents

Clinical Cancer Drugs, Volume 4 - Number 2


Review Article

Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 1 – Where Do We Stand?

, 4(2): 74 - 81

Manon Launay, Joseph Ciccolini*, Anne Rodallec, Claire Fournel, Florence Duffaud, Sebastien Salas and Bruno Lacarelle


DOI: 10.2174/2212697X04666170531080625



Review Article

Pharmacokinetic Markers of 5-Fluorouracil Toxicity in Clinical Trials and Real World

, 4(2): 82 - 92

Antonello Di Paolo*, Marzia Del Re, Elena Arrigoni, Teresa Di Desidero, Eleonora Rofi, Romano Danesi and Guido Bocci


DOI: 10.2174/2212697X04666170817124625



Review Article

Fluoropyrimidine-associated Toxicities in Colorectal Cancer Patients: The Epigenetic Point of View

, 4(2): 93 - 103

Laura Bertolaso* and Milena Gusella


DOI: 10.2174/2212697X04999171106143135



Review Article

Dermatological, Cardiovascular and Neurological Morphohistopathological Effects of Fluoropyrimidine-based Chemotherapy in Humans

, 4(2): 104 - 111

Gianfranco Natale*, Antonello Di Paolo and Guido Bocci


DOI: 10.2174/2212697X04666171110190256



Research Article

Prevention of Capecitabine Toxicity Using a 5-FU Test Dose

, 4(2): 112 - 121

Teresa Di Desidero, Cecilia Barbara, Paola Orlandi, Anna Fioravanti, Fotios Loupakis, Chiara Cremolini, Giacomo Allegrini, Antonello Di Paolo, Alfredo Falcone, Romano Danesi and Guido Bocci*


DOI: 10.2174/2212697X04666170504144550



Research Article

Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 2- Application to Head-and-Neck Cancer Patients

, 4(2): 122 - 128

Manon Launay, Joseph Ciccolini*, Claire Fournel, Carmello Blanquicett, Charlotte Dupuis, Nicolas Fakhry, Florence Duffaud, Sebastien Salas and Bruno Lacarelle


DOI: 10.2174/2212697X04666170817123425



Review Article

Progress and Obstacles in the Application of Precision Medicine in the Management of Hepatocellular Carcinoma

, 4(2): 129 - 134

Ping Wang and Xueying Sun*


DOI: 10.2174/2212697X04666170817125451



Research Article

Intra-arterial Temozolomide, Osmotic Blood-brain Barrier Disruption and Radiotherapy in a Rat F98-Glioma Model

, 4(2): 135 - 144

Annie I. Drapeau, Marie-Belle Poirier, Guru-Swamy Madugundu, J. Richard Wagner and David Fortin*


DOI: 10.2174/2212697X04666170727152212



Research Article

Salvage Hypofractionated Radiotherapy in Combination with Bevacizumab in Patients with Recurrent High Grade Glioma: A Mono-institutional Experience

, 4(2): 145 - 149

Francesco Pasqualetti*, Durim Delishaj, Alessandra Gonnelli, Alessandro Molinari, Martina Cantarella, Stefano Ursino, Maria Grazia Fabrini, Mirco Cosottini and Fabiola Paiar


DOI: 10.2174/2212697X04666171002153516







Editor-in-Chief

Giulio Francia
The University of Texas
El Paso, TX
USA

Biography View Full Editorial Board

Journal History

Clinical Cancer Drugs was introduced in 2014 with the assistance of Dr. Giulio Francia, who is the current Editor-in-Chief serving since 2014.
Track Your Manuscript:


Related Journals

Related eBooks

eBooks Catalog